Ardelyx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.About ARDX
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines.
CEOMichael G. Raab
CEOMichael G. Raab
Employees395
Employees395
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2007
Founded2007
Employees395
Employees395
ARDX Key Statistics
Market cap811.08M
Market cap811.08M
Price-Earnings ratio-14.89
Price-Earnings ratio-14.89
Dividend yield—
Dividend yield—
Average volume8.18M
Average volume8.18M
High today$3.41
High today$3.41
Low today$3.21
Low today$3.21
Open price$3.27
Open price$3.27
Volume4.12M
Volume4.12M
52 Week high$8.06
52 Week high$8.06
52 Week low$3.21
52 Week low$3.21
ARDX News
Simply Wall St 22h
Benign Growth For Ardelyx, Inc. Underpins Stock's 28% PlummetTo the annoyance of some shareholders, Ardelyx, Inc. ( ) shares are down a considerable 28% in the last month, which continues a horrid run for the company. The...
Simply Wall St 7d
David Mott Bought 19% More Shares In ArdelyxArdelyx, Inc. ( ) shareholders (or potential shareholders) will be happy to see that the Independent Chairman of the Board, David Mott, recently bought a whoppi...
Analyst ratings
83%
of 12 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.